Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-24 @ 4:54 PM
Study NCT ID:
NCT04531150
Status:
COMPLETED
Last Update Posted:
2025-03-30
First Post:
2020-08-24
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects
Sponsor:
Inversago Pharma Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-16
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-24
First Submit QC Date:
None
Study First Post Date:
2020-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-25
Last Update Post Date:
2025-03-30
Last Update Post Date Type:
ACTUAL